25 agosto 2015
A new study indicates that variations in opioid receptor genes are associated with more severe neonatal abstinence syndrome (NAS) in newborn babies. The findings could help lead to the development of individualized treatment plans tailored to each infants’ risk of requiring medication to curb their NAS symptoms, which could help improve these patients’ outcomes and reduce how long some stay in the hospital.
http://www.sciencedaily.com/releases/2015/08/150825141321.htm
